FEATURED
Valneva’s COVID-19 Vaccine Candidate Shows Positive Results in Phase 3 Trial
French pharmaceutical company Valneva has reported positive results for its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001 in the Phase 3
DEALS
Takeda and JCR to Commercialize Next-Gen Hunter Syndrome Therapy
Takeda and JCR Pharmaceuticals announced today a geo-based exclusive collaboration and license agreement to commercialize JR-141 (INN: pabinafusp alfa), an
PRESS RELEASES
EUCODIS‘ Scientists Help Pave the Way Towards Better Understanding of LPMOs
Scientists from EUCODIS Bioscience, a leading Austrian enzyme engineering and manufacturing company, have contributed to new findings on structural and
Comments & Analysis
Machine Learning Tissue Classifiers Power AI in Clinical Research
Machine learning tissue classifiers are one of the most powerful and promising AI-based clinical research solutions for all types of
RESOURCES
Download the latest pharmaceutical case studies, white papers, research papers and product brochures
Secure Software for Data Integrity Aids Regulatory Compliance
In the highly regulated pharmaceutical industry rigorous and accountable digital record keeping is paramount. A Gemini Data Loggers White Paper
LATEST PROJECTS
Rosalind Franklin Institute, Novel Biological Imaging Technologies, UK
The Rosalind Franklin Institute, a new research institute dedicated to developing novel technologies to tackle important health research challenges has
CLINICAL TRIALS
Valneva’s COVID-19 Vaccine Candidate Shows Positive Results in Phase 3 Trial
French pharmaceutical company Valneva has reported positive results for its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001 in the Phase 3
REGULATORY
FDA Expands Use of COVID-19 Vaccine Booster Dose in Eligible Populations
The US Food and Drug Administration has granted approval for administration of COVID-19 vaccine booster dosage, upgrading the emergency use
